Fatal cardiac arrest in an adult patient with euthyroid anti-SSA/Ro-positive connective tissue disease: a case report by Adami, Michele et al.
BioMed  Central
Page 1 of 4
(page number not for citation purposes)
International Archives of Medicine
Open Access Case report
Fatal cardiac arrest in an adult patient with euthyroid 
anti-SSA/Ro-positive connective tissue disease: a case report
Michele Adami1, Michele Nardin2, Enrico Morello3, Claudio Crivellaro1 and 
Christian J Wiedermann*1
Address: 1Department of Internal Medicine, Central Hospital of Bolzano, Lorenz-Böhler-Street 5, IT-39100 Bolzano, Italy, 2Division of 
Anaesthesiology and Intensive Care Medicine 2, Central Hospital of Bolzano, Lorenz-Böhler-Street 5, IT-39100 Bolzano, Italy and 3Department of 
Haematology, Central Hospital of Bolzano, Lorenz-Böhler-Street 5, IT-39100 Bolzano, Italy
Email: Michele Adami - michele.adami@asbz.it; Michele Nardin - michele.nardin@asbz.it; Enrico Morello - enrico.morello@asbz.it; 
Claudio Crivellaro - claudio.crivellaro@asbz.it; Christian J Wiedermann* - christian.wiedermann@asbz.it
* Corresponding author    
Abstract
Background: Until recently, anti-SSA/Ro antibodies were not considered pathogenic for severe
heart disease in adults. Prolongation of the mean QTc interval in electrocardiograms of adult
patients with anti-SSA/Ro-positive connective tissue disease has been reported and could
contribute to complex arrhythmias in such patients. Furthermore, complete heart block may also
be related to these autoantibodies.
Case presentation: We describe the occurrence of fatal complete heart block in a euthyroid
adult patient with undifferentiated connective tissue disease and polyglandular autoimmune
syndrome type 2 associated with cardiovascular autonomic dysfunction who had normal QTc
interval. The patient's serum contained anti-SSA/Ro.
Conclusion: This case might indicate that, although the adult heart conduction system may be
relatively resistant to the development of anti-Ro-associated complete heart block, cardiac arrest
may develop and even be fatal.
Background
The role of anti-SSA/Ro antibodies in the development of
congenital heart block is now established [1]. Until
recently, anti-SSA/Ro antibodies were not considered
pathogenic for severe heart disease in adults. In mixed (M)
connective tissue disease (CTD), minor cardiac rhythm
abnormalities appear in approximately half of the adult
patients [2]. Prolongation of the mean QTc interval in
electrocardiograms of adult patients with anti-SSA/Ro-
positive CTD has been reported and could contribute to
complex arrhythmias in such patients [3]. Furthermore,
complete heart block may also be related to these autoan-
tibodies [4-6]. We report a patient with cardiovascular
autonomic dysfunction and newly diagnosed undifferen-
tiated (U) CTD in autoimmune polyglandular syndrome
type 2 (APS-2) who developed complete atrioventricular
block with fatal outcome.
Case presentation
A 37-year-old woman with known autoimmune thyroidi-
tis and primary adrenal insufficiency of APS-2 was admit-
ted 6 months after being diagnosed with newly developed
Raynaud's phenomenon affecting the hand. Malaise,
arthralgias, muscle weakness, low-grade fever and general-
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ized lymphadenopathy had developed and persisted
despite sufficient hormone replacement with thyroxin
and cortisone acetate. She tolerated exposure to ultravio-
let light. Medication history included no drugs typically
known to trigger CTD nor was she exposed to silica or cig-
arette smoke. There were no seizures or other neuro-psy-
chiatric symptoms in the past.
Examination disclosed total hand edema in addition to
generalized brown hyperpigmentation. Vital signs were
normal and there were no signs and symptoms of severe
renal, cardiac, pulmonary or central nervous system dis-
ease. Cough, dyspnea or pleuritic chest pain was absent.
Chest x-ray and electrocardiogram were unremarkable.
The QTc interval was normal at the electrocardiogram.
Results of laboratory tests are given in Table 1. The patient
displayed positivity for anti-SSA/Ro antibodies. Serum
electrophoresis showed polyclonal hypergammaglob-
ulinemia, negative for monoclonality on immune fixa-
tion; in bone marrow biopsy, hyperplasia was found
predominantly of normal granulopoiesis and mild infil-
tration of B lymphocytes of about 8%; anti-Sm antibodies
were only transiently positive on admission (negative
after two additional weeks); in morphological and immu-
nophenotypic analyses of supraclavicular and abdominal
lymph node biopsies, follicular hyperplasia was seen
which was interpreted as reactive lymph node changes.
Normal fT4 excludes clinical hypothyroidism. Reduced
fT3 and slightly elevated TSH levels indicate presence of
the euthyroid sick syndrome.
Ambulatory electrocardiography for 24 hours showed a
heart rate variability that was pathologically reduced.
Orthostatic hypotension was symptomatic in the absence
of volume depletion. Echocardiography confirmed near-
normal left ventricular function and excluded structural
heart disease. The patient received hormone replacement
with thyroxin and intravenous hydrocortisone (240 μg
per day); omeprazol 40 mg and thrombosis prophylaxis
with enoxaparin 40 mg were given daily.
Before initiation of therapy for CTD, the patient became
unresponsive on the general ward with no normal breath-
ing and no signs of circulation. Sudden cardiac arrest
occurred unwitnessed with cessation of cardiac activity of
unknown duration. On emergency ECG monitoring, wide
QRS escape rhythm was seen of frequency < 20 bpm with
increasing periods of asystole. Complete heart block was
successfully reversed to spontaneous circulation by cardi-
opulmonary resuscitation with chest compression, and
administration of atropine and adrenaline. Severe anoxic
brain injury was subsequently diagnosed (corneal and
pupillary light reflexes absent for 24 hours; Glasgow
Coma Scale score of 3 after 48 hours). When complete
heart block developed, electrolytes were normal, serial
troponin T measurement ruled out acute coronary syn-
drome and post-resuscitation 12-lead ECG did not show
sign of ischemia or myocarditis. The patient progressed to
a persistent vegetative state and, just 2 months later, died
a natural death in a long-term care facility of a repeat epi-
sode of cardiac arrest.
Discussion
UCTD was diagnosed as defined by Raynaud's phenome-
non with swollen hands and highly positive anti-RNP
antibody titer, associated with autoimmune conditions
including hypergammaglobulinemia, reactive lymphade-
nopathy, Coombs'-positive anemia, and APS-2. The
patient had cardiovascular autonomic dysfunction as evi-
denced by symptomatic orthostatic hypotension in the
absence of volume depletion as well as significantly
reduced heart variability on ambulatory electrocardiogra-
phy. Following development of complete heart block,
electrophysiological studies and eventual pacemaker
insertion were not performed because of severe neurolog-
ical disability and poor prognosis.
Table 1: Laboratory studies
Parameter Level Normal
TSH 13.83 mIU/L 0.30 – 3.94
T3 1.89 pg/mL 2.42 – 4.36
ACTH 1601 pg/mL 5.0 – 47.0
Hematocrit 29.7% 37 – 52
Hemoglobin 9.9 g/dL 12 – 18)
Immunoglobulin G 4040 mg/dL 751 – 1560
Kappa light chains 48.7 mg/dL absent
Direct Coombs' positive negative
Beta-2 microglobulin 4.2 mg/L 1.0 – 1.9
D-dimer 2527 ng/ml <500
Factor V Leiden mutation heterozygote absent
ANA > 1/1280 "speckled" absent
RNP/Sm positive negative
SS-A/Ro positive negative
Test results within normal range: electrolytes (including calcium), 
glucose, kidney and liver function tests, white blood cell count with 
differential and platelets, free T4, IgM, IgA, indirect Coombs' test, 
erythrocyte sedimentation rate, C-reactive protein, troponin T; global 
coagulation parameters; urine analysis, urinary free lambda light 
chains; anti-extractable nuclear antigens antibodies (SS-B/La, Scl-70 
and Jo-1), anti-dsDNA; anti-mitochondrial (AMA), anti-neutrophil 
cytoplasmic (ANCA) against myeloperoxidase (MPO) and proteinase-
3 (PR3), anti-liver kidney microsomal, anti-parietal cell, anti-
transglutaminase IgA and IgG, and anti-cardiolipin IgG and IgM 
antibodies; rheumatoid factor; angiotensin converting enzyme; 
complement levels C3 and C4; candida culture, serology on single 
determination for hepatitis viruses A, B and C, human 
immunodeficiency virus antigen/antibody, cytomegalovirus, herpes 
simplex virus-1 and -2, and varicella-zoster virus. Elevated ACTH 
reduced within days to normal values upon administration of 
increased doses of cortisone acetate resulting in cortisol levels of 
around 400 ng/mL (normal range: 65 – 250).
Abbreviations: ANA, antinuclear antibodies; RNP/Sm, combined 
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Cardiac arrhythmias have been described in autoimmune
diseases with antibodies causing inflammatory myopa-
thies [7]. In the current patient, anti-SSA/Ro antibodies
may well have contributed to the development of sudden
cardiac arrest. A high titer of anti-RNP antibodies in
patients with UCTD is a powerful predictor of later evolu-
tion into mixed (M)CTD [8], for which anti-Ro/SSA-medi-
ated non-fatal complete heart block has been reported as
rare event [1,4-6]. The patient reported here did not yet
fulfil diagnostic criteria for MCTD. As she was positive for
both anti-RNP and anti-SSA, however, the presence of
anti-RNP antibodies could be predictive of later develop-
ment of MCTD.
Signs of an autonomic nervous system dysfunction
involving the cardiovascular system can be discerned in
the majority of anti-SSA/Ro- and anti-SSB/La-positive
patients with CTD [3]; on this basis, a putative role for car-
diovascular autonomic dysfunction in favoring an adverse
outcome of complete heart block by impairment of com-
pensatory shock mechanisms as was seen in the present
patient, cannot be ruled out. Moreover, it should be
underlined that cardiovascular autonomic dysfunction
was similarly detected in anti-SSA/Ro-negative CTD
patients [3], as it is present in other autoimmune diseases
as well [9], thus suggesting that it is a feature characteristic
of the disease independently of the presence of such
autoantibodies.
Hypothyroidism at the moment of the cardiac arrest may
be a feature of peculiar pathogenetic relevance. In fact, in
patients with hypothyroidism (also subclinical), severe
atrioventricular block of different degrees disappeared
after supplementation with thyroxine [10,11]. Moreover,
Spence et al. [12] demonstrated that maternal hypothy-
roidism increased markedly the risk (about 9-fold) of
delivering a child with complete congenital heart block in
women with circulating anti-SSA/Ro antibodies. Finally,
Baumgart et al. [13] described the case of a complete heart
block developing in a woman affected by anti-60 kD SSA/
Ro-positive Sjögren's syndrome with concomitant
hypothyroidism and hypoadrenalism secondary to hypo-
pituitarism. The patient, early implanted with a VVI pace-
maker, was then treated with a substitution regimen with
prednisolone and thyroxine resulting in the restoration of
the sinus rhythm. On the basis of these data, in accord-
ance with a very recent review on this topic [1], it is possi-
ble to hypothesize that the conduction system of adult
heart may display, rather than an absolute resistance, a
different degree of vulnerability to anti-SSA/Ro antibodies
with respect to fetal heart.
Two fundamental pathophysiological mechanisms have
been proposed to account for autoantibody-mediated
arrhythmogenic effects: (a) a direct mechanism, in which
cardiomyocytes, and their electrophysiological properties,
constitute the primary target of the autoantibodies; (b) an
indirect mechanism, in which the autoantibody-mediated
immune response involves the cardiac electrophysiology
only secondarily [14]. The latter is the case of anti-cardio-
myocyte autoantibodies producing a myocardial damage
leading to the development of dilated cardiomyopathy
and heart failure, which eventually represent the major
cause of severe ventricular arrhythmias), or autoantibod-
ies targeting structures indispensable for the myocardial
homeostasis such as nerves and vasculature (references in
[14]). Given the absence of both clinical and objective
findings suggesting dilated cardiomyopathy in the case
presented here, a direct mechanism most likely accounted
for bradycardia.
In the context of predisposition, additional concomitant
factors (such as hypothyroidism) may be able to precipi-
tate the onset of severe heart block. The patient of the
present case report was not in a hypothyroid state at the
moment of heart block development as fT4 levels were
normal because sufficiently substituted with thyroxine.
TSH was slightly elevated and fT3 was low which is com-
patible with euthyroid sick syndrome [15].
Differential diagnoses of bradycardia and complete heart
block have to be reasonably ruled out. The patient pre-
sented here did not assume medications potentially affect-
ing the conduction tissue; clinical, laboratory and ECG
data suggesting structural heart disease were normal, mak-
ing underlying myocarditis and acute myocardial infarc-
tion unlikely, putatively resulting from coronary vasculitis
or accelerated atherosclerosis, nor were echocardiographic
signs of cardiac amyloidosis present in consideration of
the concomitant cardiovascular autonomic dysfunction
evident.
The fact that a post-mortem examination has not been
performed in the patient is a clear limitation of the study.
Conclusion
CTD may accompany APS-2 and in such patients should
be considered in the differential diagnosis of otherwise
unexplained symptomatology. The presence of anti-Ro/
SSA-antibodies may cause atrio-ventricular conduction
disturbance and bradycardia, the clinical significance of
which can be evaluated by ambulatory electrocardiogra-
phy for 24 or 48 hours. The conduction system of adult
heart may display a different degree of vulnerability to
anti-SSA/Ro antibodies and concomitant risk factors
including hypothyroidism.
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